| 35407-6 |
Leishmania mexicana Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Leishmania mexicana IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35407-6 |
|
|
|
|
Both |
|
|
|
0 |
L mexicana IgM Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; L mexicana; Leishmaniasis; Leishmaniosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.13 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 35408-4 |
Leishmania tropica Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Leishmania tropica IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35408-4 |
|
|
|
|
Both |
|
|
|
0 |
L tropica IgG Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; L tropica; L tropicalis; Leishmaniasis; Leishmaniosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.13 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 35409-2 |
Leishmania tropica Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Leishmania tropica IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35409-2 |
|
|
|
|
Both |
|
|
|
0 |
L tropica IgM Ser Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; L tropica; L tropicalis; Leishmaniasis; Leishmaniosis; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.56 |
2.13 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 3541-0 |
Dextromoramide |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Dextromoramide [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
3541-0 |
|
|
|
|
Both |
|
|
|
0 |
D-moramide Ur-mCnc |
|
|
|
Y |
|
Dextrodiphenopyrine; Dextro-moramide; D-moramid; D-moramide; DRUG/TOXICOLOGY; Drugs; Jetrium; Level; Mass concentration; Narcolo; Palfium; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.42 |
1 |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 35410-0 |
Pressure.continuous positive airway |
Pres |
Respiratory system |
Pt |
Qn |
|
|
ACTIVE |
Continuous positive airway pressure Respiratory system |
|
MIN |
DefinitionDescription |
|
|
cm H2O |
|
|
|
|
|
|
PULM |
|
35410-0 |
|
|
|
|
Observation |
|
|
|
0 |
CPAP Respiratory |
|
|
|
N |
|
Breathing; CPAP; Lung; Lungs; Point in time; Pos; Pressure; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; RS |
2.73 |
2.13 |
|
|
|
|
|
|
|
cm[H2O] |
|
|
|
0 |
| 35411-8 |
Trienoate/Arachidonate |
SRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Trienoate (C20:3w9)/Arachidonate (C20:4w6) [Molar ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
|
|
|
|
CHEM |
|
35411-8 |
|
|
|
|
Observation |
|
|
|
0 |
Trienoate/AA SerPl-sRto |
|
|
|
N |
|
5,8,11,14 Eicosatetraenoic acid; 5,8,11-eicosatrienoic acid 20:3 w9; AA; Arachidonic acid; Arch acid; C20:4w6; Chemistry; Eicosatetraenoate; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration ratio; Substance ratio; Trienoic acid |
2.73 |
2.13 |
|
|
|
|
|
|
|
{ratio} |
|
|
Corrected Example and UCUM Units. |
0 |
| 35412-6 |
Chlamydia sp DNA |
PrThr |
Nose |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Chlamydia sp DNA [Presence] in Nose by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35412-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
Chlamydia DNA Nose Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Chlam; Chlamid; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Smell; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.63 |
2.13 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 35413-4 |
Coxsackievirus A4+A16 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Coxsackievirus A4+A16 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
35413-4 |
|
|
|
|
Observation |
|
|
|
0 |
CV A4+A16 Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAV; Coxsackie; Coxsackie virus; CV; CV A4; CV A4+A16; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.13 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 35414-2 |
Observation |
SpGrav |
Body fld |
Pt |
Qn |
Refractometry |
|
ACTIVE |
Specific gravity of Body fluid by Refractometry |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
35414-2 |
|
Refractometry |
|
|
Both |
|
|
|
0 |
Sp Gr Fld Refractometry |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Chemistry; Fl; Fld; FLU; Fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; Refract; Sp Gr |
2.79 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by coll w SCT: component that the description is property like as in Color, Appearance, Osmolality have changed to Component: Observation, and Property: Color, or Appearance, or Osmolality, so forth�; |
0 |
| 35415-9 |
Oxytocin |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Oxytocin [Units/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
uIU/mL |
|
|
|
|
|
|
CHEM |
|
35415-9 |
|
|
|
|
Both |
|
|
|
0 |
Oxytocin SerPl-aCnc |
|
|
|
N |
|
Arbitrary concentration; Chemistry; Ocytocin; OXT; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.7 |
2.13 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 35416-7 |
Echinococcus granulosus Ab |
PrThr |
Ser |
Pt |
Ord |
IB |
|
ACTIVE |
Echinococcus granulosus Ab [Presence] in Serum by Immunoblot |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35416-7 |
|
IB |
|
|
Both |
|
|
|
0 |
E granulosus Ab Ser Ql IB |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blt; E granulosus; Echinococcosis; ID; IMMUNE BLOT; Immunobl; Immunoblot; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; RIBA; Screen; Serum; SR; WB; WBLOT; West blot; West blt; Western blot |
2.58 |
2.13 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 35417-5 |
Herpes simplex virus |
Prid |
Anal |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Anal by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35417-5 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Anal Cult |
|
|
|
N |
|
Anus; C&S; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Rectal specimen; Spec |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35418-3 |
Herpes simplex virus |
Prid |
Bronchial |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Bronchial specimen by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35418-3 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Bronch Cult |
|
|
|
N |
|
Bro; C&S; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35419-1 |
Herpes simplex virus |
Prid |
CSF |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Cerebral spinal fluid by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35419-1 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV CSF Cult |
|
|
|
N |
|
C&S; Cerebral spinal fluid; Cerebrospinal Fl; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Nominal; Point in time; Random; Spec; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 3542-8 |
Propoxyphene |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Propoxyphene [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
3542-8 |
|
|
|
|
Both |
|
|
|
0 |
Propoxyph SerPl Ql |
|
|
|
|
|
Addiction; Algaphan; Cosalgesic; Cotonal-65; Darvon; Depronal; Dextrogesic; Dextropropoxyphene; Distalgesic; Dolasan; Doloxene; D-propoxyphene; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Napsalgesic; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 35420-9 |
Herpes simplex virus |
Prid |
Cvx |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Cervix by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35420-9 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Cvx Cult |
|
|
|
N |
|
C&S; Cervix; Cult; Cultures; Genital tract; Gyn; Gynecology; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Spec |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35421-7 |
Herpes simplex virus |
Prid |
Ear |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Ear by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35421-7 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Ear Cult |
|
|
|
N |
|
C&S; Cult; Cultures; Hearing; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Otologic; Point in time; Random; Spec |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35422-5 |
Herpes simplex virus |
Prid |
Body fld |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Body fluid by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35422-5 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Fld Cult |
|
|
|
N |
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Spec |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35423-3 |
Herpes simplex virus |
Prid |
Vag |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Vaginal fluid by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35423-3 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Vag Cult |
|
|
|
N |
|
C&S; Cult; Cultures; Genital vaginal; Gyn; Gynecology; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; OB; ObGyn; Obstetrics; Point in time; Random; Spec; UniversalLabOrders; Vag fld; Vag fluid; Vagina; Vaginal fluid |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35424-1 |
Herpes simplex virus |
Prid |
Penis |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Penis by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35424-1 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Penis Cult |
|
|
|
N |
|
C&S; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Pen; Penile; Point in time; Random; Spec |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35425-8 |
Herpes simplex virus |
Prid |
Placenta |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Placenta by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35425-8 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Placenta Cult |
|
|
|
N |
|
C&S; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Placent; Placental; Point in time; Random; Spec |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; Previous Releases: Changed System from Placent to Placenta so that all terms with a System of Placenta are consistent. |
0 |
| 35426-6 |
Herpes simplex virus |
Prid |
Plr fld |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Pleural fluid by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35426-6 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Plr Cult |
|
|
|
N |
|
C&S; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Nominal; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec; thoracentesis fluid |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35427-4 |
Herpes simplex virus |
Prid |
Periton fld |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Peritoneal fluid by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35427-4 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Prt Cult |
|
|
|
N |
|
Ascites; Ascitic fluid; Ascitis; C&S; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Peritoneal fluid; Point in time; Prt; Random; Spec |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35428-2 |
Herpes simplex virus |
Prid |
Synv fld |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Synovial fluid by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35428-2 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Snv Cult |
|
|
|
N |
|
C&S; Cult; Cultures; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; Microbiology; Nominal; Point in time; Random; Rheum; Rheumatology; SF; SNV; Spec; Syn; Syn fl; Synov; Synovial fluid |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
| 35429-0 |
Herpes simplex virus |
Prid |
Stool |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Herpes simplex virus identified in Stool by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
35429-0 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
HSV Stl Cult |
|
|
|
N |
|
Bowel movement; C&S; Cult; Cultures; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; Herp splx; HSV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; Spec; Stl; Stool = Fecal |
2.78 |
2.13 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
